The production of radioisotopes used in medicine has continued during the COVID-19 pandemic, but hospitals could face shortages due to bottlenecks in transport and distribution. This is the picture emerging from a survey conducted by the IAEA among research reactors that produce radioisotopes for radiopharmaceuticals – medicines containing small amounts of radioactive isotopes used for the diagnosis and management of some cancers and chronic diseases.
To read more please visit:
Source: IAEA